Adaptive Biotechnologies (ADPT) Amortization - Intangibles (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Amortization - Intangibles of $419000.0 for Q1 2026, down 2.33% sequentially from $429000.0 in Q4 2025, and little changed YoY from $419000.0 in Q1 2025.
Adaptive Biotechnologies (ADPT) Amortization - Intangibles (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Amortization - Intangibles for 9 years, with the latest figure at $419000.0 in Q1 2026.
- Quarterly Amortization - Intangibles changed 0.0% year-over-year to $419000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $1.7 million, changed 0.23% from the prior year.
- Amortization - Intangibles declined to $419000.0 in Q1 2026 per ADPT's latest filing, from $429000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $429000.0 in Q4 2022 and troughed at $419000.0 in Q1 2022.
- A 5-year average of $424647.1 and a median of $424000.0 in 2024 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles climbed 0.95% in 2024, then retreated 0.95% in 2025.
- Over 5 years, Amortization - Intangibles stood at $429000.0 in 2022, then changed by 0.0% to $429000.0 in 2023, then decreased by 0.23% to $428000.0 in 2024, then grew by 0.23% to $429000.0 in 2025, then decreased by 2.33% to $419000.0 in 2026.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $419000.0, $429000.0, and $428000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 429,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Jun 30, 2025 | 423,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | 428,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | 429,000.00 |
| Sep 30, 2023 | 428,000.00 |
| Jun 30, 2023 | 423,000.00 |
| Mar 31, 2023 | 419,000.00 |
| Dec 31, 2022 | 429,000.00 |
| Sep 30, 2022 | 428,000.00 |
| Jun 30, 2022 | 423,000.00 |
| Mar 31, 2022 | 419,000.00 |
| Dec 31, 2021 | 429,000.00 |
| Sep 30, 2021 | 428,000.00 |
| Jun 30, 2021 | 423,000.00 |